[1]
L. D. KHATAL and H. More, “In-vitro assessment of CYP3A4 and CYPC29 inhibition potential of Lupeol using human liver microsomes”, J. Drug Delivery Ther., vol. 9, no. 2, pp. 231–236, Mar. 2019, doi: 10.22270/jddt.v9i2.2562.